CIK 0000926617 · Non-accelerated filer<br>Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330595156
- Phone
- 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- 4 Open-market buy Executive Chair bought 43,994 shares at $0.57 ($24,918)
- 8-K Event Regulation FD disclosure
- 4 Open-market buy President and CEO bought 98,000 shares at $0.76 ($74,892)
- 10-Q Report Quarterly Report
- DEFA14A Proxy Proxy Materials
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Grant or award Director acquired 73,656 shares (grant or award)
- 4 Grant or award Director acquired 99,671 shares (grant or award)
- 4 Grant or award Director acquired 72,937 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award President and CEO acquired 23,033 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure
Page 20 of 78 · 1,549 filings